---
title: "The Hang Seng TECH Index turned negative again during the session, after briefly rising by 0.9%"
description: "The Hang Seng TECH Index turned negative again during the session, after briefly rising by 0.9%"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/277131330.md"
published_at: "2026-02-27T02:25:55.000Z"
---

# The Hang Seng TECH Index turned negative again during the session, after briefly rising by 0.9%

The Hang Seng TECH Index turned negative again during the session, after briefly rising by 0.9%

### Related Stocks

- [03067.HK - ISHARESHSTECH](https://longbridge.com/en/quote/03067.HK.md)
- [03033.HK - CSOP HS TECH](https://longbridge.com/en/quote/03033.HK.md)
- [03088.HK - CAM HS TECH](https://longbridge.com/en/quote/03088.HK.md)
- [STECH.HK - Hang Seng TECH Index](https://longbridge.com/en/quote/STECH.HK.md)
- [03032.HK - HSTECH ETF](https://longbridge.com/en/quote/03032.HK.md)
- [02837.HK - GX HS TECH](https://longbridge.com/en/quote/02837.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Kuaishou Technology published an update to their financial calendar | Kuaishou Technology will announce its Q4 and full-year 2025 financial results on March 25, 2026, after the Hong Kong mar | [Link](https://longbridge.com/en/news/277165672.md) |
| AI apps soar in China as Lunar New Year giveaway battle boosts user growth | Chinese tech giants have reported significant user growth for their AI applications during a promotional campaign for th | [Link](https://longbridge.com/en/news/276715596.md) |
| Kennedy is funding dangerous science to validate his anti-vaccine agenda | Health and Human Services Secretary Robert F. Kennedy Jr. is funding controversial research that undermines vaccine impo | [Link](https://longbridge.com/en/news/276909962.md) |
| U.S. CDC says meeting of U.S. CDC vaccine advisors to be held on March 18-19, website shows | U.S. CDC says meeting of U.S. CDC vaccine advisors to be held on March 18-19, website shows | [Link](https://longbridge.com/en/news/276759140.md) |
| A Look At Sartorius Stedim Biotech (ENXTPA:DIM) Valuation After Robust Full Year 2025 Results | Sartorius Stedim Biotech (ENXTPA:DIM) reported full year 2025 results with sales of €2,967.5m and net income of €265.6m. | [Link](https://longbridge.com/en/news/276575777.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.